In November 2003, the Legal Network convened a meeting in Montréal of global experts working in the fields of treatments, vaccines, and microbicides.The meeting was historic in that it was the first occasion on which advocates from the three fields had the opportunity to meet and exchange views on policy priorities. In this article, John … Read more
In the space of a few weeks in January 2004, actions by three different institutions in Quebec combined to threaten the human rights of people living with HIV/AIDS, raise the spectre of mandatory HIV testing, and create unnecessary public fears about the spread of HIV infection. In response to what they called “the worst weeks … Read more
FEATURE HIV treatments, vaccines, and microbicides: toward coordinated advocacy CANADIAN NEWS Québec: An outbreak of HIV/AIDS-related stigma and discrimination Alberta: New bill will allow for mandatory HIV testing in emergency situations Media frenzy greets release of Newfoundland man from prison Health Canada makes marijuana available for medical use AIDS in the workplace: a program that’s … Read more
This is a series of seven info sheets: The Importance of Privacy of Health Information for People Living with HIV/AIDS Privacy, Confidentiality, and Privilege: Related Legal Concepts Legal Protection of Privacy and Confidentiality in Canadian Law Privacy Principles Limits on Privacy and Confidentiality of Health Information Patient Confidentiality and Preventing Harm to Others Privacy Protection … Read more
This info sheet is one in a series of seven info sheets on the federal regulation of pharmaceutical prices in Canada. Health Spending and the Pharmaceutical Industry Controlling Medicine Prices: Evolution of Canadian Law Patented Medicine Prices Review Board Preventing Excessive Pricing of Patented Medicines Jurisdiction of the PMPRB Pricing of HIV/AIDS Drugs Trends in … Read more
“I write to follow up on our previous submissions to the Standing Committee regarding Bill C-9, Canada’s laudable initiative to implement the WTO General Council Decision of August 30, 2003 to enable countries lacking sufficient pharmaceutical manufacturing capacity to ‘make effective use’ of compulsory licensing to obtain lower cost generic pharmaceutical products manufactured in Canada…”
“As was requested by the Committee when we appeared before you on February 26, 2004, we have provided the Committee with our supplementary submissions regarding the alternatives to the ‘right of refusal’ that had been proposed to the Committee… “However, discussions at subsequent Committee meetings have indicated that Committee members are under a fundamental misapprehension … Read more
This resource guide is intended to provide concise, accurate information and practical tools so that people living with HIV/AIDS (PHAs) and community based AIDS organizations (CBAOs) can make informed and empowered choices about how to respond to the complex legal and ethical issues related to HIV disclosure.
The Standing Committee has asked that we provide our views regarding the “alternatives” to the right of refusal that have been put forward by other witnesses appearing before the Committee. We address several of the most important points that have been put before the Committee.